小分子化合物通过准门户蛋白质-囊体接口来抑制疹病毒复制
Julius Svensmark1, Emily Polk1, Ellyn Kornfeind1
1Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
Viruses
|November 27, 2025
概括
脊髓灰质炎病毒 (VZV) 门蛋白pORF54是抑制病毒DNA封装的尿素化合物的标. 药物耐药性突变揭示了这些化合物如何破坏基因组包装必不可少的门相互作用.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 脊髓灰质炎病毒 (VZV) 使用pORF54门户蛋白 dodecamer 将其基因组包装成预制的囊体.
- α-甲基基尿素化合物抑制VZVDNA封装,pORF54被确定为可能的目标.
- 了解pORF54在病毒DNA包装中的作用对于开发抗病毒疗法至关重要.
研究的目的:
- 调查针对VZV pORF54.54.的α-甲基基尿酸化合物的作用机制.
- 为了识别和描述赋予对这些抗病毒化合物的耐药性的突变.
- 阐明在VZVDNA封闭中门接口的作用.
主要方法:
- 产生和分析VZV耐药分离物.
- 使用测序识别pORF54基因中的突变.
- 对表达特定pORF54突变的复合病毒的构造和特征.
- 利用一种新的补充细胞系来评估DNA封装效率.
主要成果:
- 四个耐药的VZV分离体在pORF54.5的氨基酸48,304,324和407中表现出突变.
- 这些突变局部化到预测的门-囊接口.
- 再组合病毒证实了这些突变在赋予耐药性的重要性.
- 补充细胞系表明,单独存在pORF54并不能确保DNA封闭.
结论:
- α-甲基基尿素化合物可能通过破坏在门接口或附近的相互作用来抑制VZVDNA封装.
- 这些化合物防止了基因组包装所需的pORF54的基本形状变化.
- 鉴定出的抗性突变提供了关于门-囊相互作用部位的结构和功能意义的见解.
相关概念视频
Subviral Agents
485
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
485
Viral Structure
73.7K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
73.7K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
189
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
189
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
799
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
799
Viruses with RNA Genomes
765
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
765


